Genetron Health to Present at Upcoming Investor Conferences
September 08 2020 - 4:15PM
Genetron Holdings Limited (“Genetron Health” or the “Company”,
NASDAQ: GTH), a leading precision oncology platform company in
China that specializes in offering molecular profiling tests, today
announced that its executive management team will participate in
the following conferences.
- ICBCI International ADR New Economy Conference from September
15-18, 2020: Management will be available for virtual one on one
and group meetings on September 15, 2020.
- SVB Leerink CyberRx Series: Oncology Dx and Liquid Biopsy
Summit on October 6, 2020: Management will participate in a virtual
video fireside chat on October 6 at 9:00 am ET.
Interested parties may request more information
by contacting their sales representatives at ICBCI and SVB Leerink,
respectively.
About Genetron Holdings LimitedGenetron
Holdings Limited (“Genetron Health” or the “Company”) is a leading
precision oncology platform company in China that specializes in
cancer molecular profiling and harnesses advanced technologies in
molecular biology and data science to transform cancer treatment.
The Company has developed a comprehensive oncology portfolio that
covers the entire spectrum of cancer management, addressing needs
and challenges from early screening, diagnosis and treatment
recommendations, as well as continuous disease monitoring and care.
Genetron also partners with global biopharmaceutical companies and
offers customized services and products. For more information,
please visit ir.genetronhealth.com.
Safe Harbor StatementThis press release
contains forward-looking statements. These statements are made
under the “safe harbor” provisions of the U.S. Private Securities
Litigation Reform Act of 1995. Statements that are not historical
facts, including statements about the Company’s beliefs and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties, and a number
of factors could cause actual results to differ materially from
those contained in any forward-looking statement. In some cases,
forward-looking statements can be identified by words or phrases
such as “may”, “will,” “expect,” “anticipate,” “target,” “aim,”
“estimate,” “intend,” “plan,” “believe,” “potential,” “continue,”
“is/are likely to” or other similar expressions. Further
information regarding these and other risks, uncertainties or
factors is included in the Company’s filings with the SEC. All
information provided in this press release is as of the date of
this press release, and the Company does not undertake any duty to
update such information, except as required under applicable
law.
Investor Relations Contacts
US:Hoki LukHead of Investor RelationsEmail:
hoki.luk@genetronhealth.com Phone: +1 (408) 891-9255
Stephanie CarringtonWestwicke, an ICR CompanyEmail:
Stephanie.Carrington@westwicke.com Phone: +1 (646)
277-1282
Asia:Bill ZimaICR, Inc.Email:
bill.zima@icrinc.com GenetronIR@icrinc.com
Media Relations ContactEdmond
LococoICREdmond.Lococo@icrinc.comMobile: +86
138-1079-1408genetron.pr@icrinc.com
Genetron (NASDAQ:GTH)
Historical Stock Chart
From May 2024 to Jun 2024
Genetron (NASDAQ:GTH)
Historical Stock Chart
From Jun 2023 to Jun 2024